In a statement on Wednesday, the UK granted approval following months of clinical trials and studies conducted by the Medicines and Healthcare Products Regulatory Agency.
This means that the British public will be able to receive a vaccine that has a 95-percent efficacy rating as soon as next week.
The UK government has already secured enough of the two-dose vaccine to vaccinate more than 20 million people.
Following Pfizer’s statement, South Korea’s food and drug ministry says that the nation has not yet received Pfizer’s submission but the process won’t take as long as it normally would.
“Since COVID-19 vaccines are part of the Intensive and Rapid Commercialization Support Program, the whole process of receiving approval can be shortened to 40 days rather than 180 days like normal.”
After being asked when South Korea will be able to use the vaccines, the official said that there are still some parts of the process remaining and that could take longer than 40 days.
AstraZeneca is the only company to have submitted documents on non-clinical studies to the nation, and will need to submit additional paperwork in order to get final approval.
Choi Won-jong, Arirang News.